scholarly journals 3-point major cardiovascular event outcome for patients with T2D treated with dipeptidyl peptidase-4 inhibitor or glucagon-like peptide-1 receptor agonist in addition to metformin monotherapy

2020 ◽  
Vol 8 (21) ◽  
pp. 1345-1345
Author(s):  
Caroline E. El Sanadi ◽  
Xinge Ji ◽  
Michael W. Kattan
Keyword(s):  
Cardiovascular Event ◽  
Receptor Agonist ◽  
Dipeptidyl Peptidase ◽  
Major Cardiovascular Event ◽  
Dipeptidyl Peptidase 4 ◽  
Metformin Monotherapy ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function

Endocrine ◽  
2015 ◽  
Vol 51 (3) ◽  
pp. 429-439 ◽  
Author(s):  
Asuka Morita ◽  
Eri Mukai ◽  
Ayano Hiratsuka ◽  
Tomozumi Takatani ◽  
Toshihiko Iwanaga ◽  
...  
Keyword(s):  
Receptor Agonist ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Islet Morphology ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
And Function

scholarly journals Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism

Hypertension ◽  
2012 ◽  
Vol 60 (3) ◽  
pp. 833-841 ◽  
Author(s):  
Limei Liu ◽  
Jian Liu ◽  
Wing Tak Wong ◽  
Xiao Yu Tian ◽  
Chi Wai Lau ◽  
...  
Keyword(s):  
Endothelial Function ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1 ◽  
Dependent Mechanism

Is glucagon-like peptide-1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

2018 ◽  
Vol 20 (8) ◽  
pp. 1937-1943 ◽  
Author(s):  
Emilie S. Andersen ◽  
Asger Lund ◽  
Jonatan I. Bagger ◽  
Camilla Andreasen ◽  
Magnus F. Grøndahl ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

scholarly journals Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats

2015 ◽  
Vol 14 (1) ◽  
Author(s):  
Xiaoyan Zhou ◽  
Chin-hu Huang ◽  
Julie Lao ◽  
Alessandro Pocai ◽  
Gail Forrest ◽  
...  
Keyword(s):  
Dipeptidyl Peptidase ◽  
Renal Effects ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1
Sign in / Sign up

Export Citation Format

Share Document